October 2, 2024by University of Cologne ERT expression and telomerase activity in pulmonary carcinoids. Credit: Journal of Clinical Oncology (2024). DOI: 10.1200/JCO.23.02708Pulmonary carcinoids are rare tumors of the lung with extremely different clinical courses. In many patients, they behave like benign tumors; surgical removal of the tumor leads to a complete cure. However, some patients...
Tag: <span>Lung cancer</span>
Post
New drug combination shows promise for small cell lung cancer
September 30, 2024 by The Mount Sinai Hospital Researchers at the Icahn School of Medicine at Mount Sinai have made a promising breakthrough in the treatment of small cell lung cancer (SCLC). Their study, published in Science Advances and titled “ATR Inhibition Activates Cancer Cell cGAS/STING-Interferon Signaling and Promotes Anti-Tumor Immunity in Small Cell Lung...
Post
Combination treatment improves response to immunotherapy for lung cancer, mouse study shows
September 25, 2024 by The Francis Crick Institute Credit: Pixabay/CC0 Public DomainResearchers at the Francis Crick Institute, in collaboration with Revolution Medicines, have tested a combination of treatments in mice with lung cancer and shown that these allow immunotherapies to target non-responsive tumors. Their findings show that targeting tumors in different ways simultaneously might increase...
Post
Lung complications + rheumatoid arthritis increase risk for lung cancer
September 8, 2024 by Lori Solomon The risk for lung cancer is high in patients with rheumatoid arthritis (RA) and pulmonary complications, according to a study published online Sept. 3 in Modern Rheumatology. Shunsuke Mori, M.D., Ph.D., from the Kumamoto Saishun Medical Center in Koshi, Japan, and colleagues assessed the incidence and predictive factors of...
Post
Proposed lung cancer screening guideline could eliminate racial disparities, allow for early detection
August 5, 2024 by Liz Murphy, Massachusetts General Hospital Distribution of smoking duration (years), smoking intensity (cigarettes per day), and pack-year smoking history among SCCS participants diagnosed with lung cancer. SCCS, Southern Community Cohort Study. Credit: Journal of Clinical Oncology (2024). DOI: 10.1200/JCO.23.01780Early detection of lung cancer through low-dose computed tomography screening is one of...
Post
Detecting lung cancer early with sugar-sensing nanotech
JULY 1, 2024 by Australian Institute for Bioengineering and Nanotechnology (AIBN) A new nanodevice designed by AIBN researchers analyses sugars on the surface of cellular messenger particles to catch early signs of lung cancer. Credit: AIBN/UQFor such a common disease, lung cancer can be hard to spot. In the early stages you probably won’t even...
Post
‘Self-taught’ AI tool helps to diagnose and predict severity of common lung cancer
JUNE 11, 2024 by NYU Langone Health Credit: Unsplash/CC0 Public Domain A computer program based on data from nearly a half-million tissue images and powered by artificial intelligence can accurately diagnose cases of adenocarcinoma, the most common form of lung cancer, a new study shows. Researchers at NYU Langone Health’s Perlmutter Cancer Center and the...
Post
Strong trial results for Pfizer lung cancer drug
MAY 31, 2024 Credit: Unsplash/CC0 Public Domain A Pfizer medicine has been shown to greatly reduce cancer progression and improve survival outcomes for people in the advanced stages of a form of lung cancer, results published Friday showed. Lorlatinib, which is already approved and available under the brand name Lobrena in the United States, was...
Post
Healing cells going rogue in common lung cancer
Researchers uncover lung adenocarcinoma’s early roots, tracing the cancer back to a specific cell type. These insights offer new hope for detection and prevention. Produced by Nature Research Custom MediaMD Anderson Markers of alveolar intermediate cells, termed KRT8+ alveolar cells (KACs), identified by Kadara and colleagues within a lung tumour. KRT8 in shown in red,...
Post
AI Outscores Pathologists Predicting Lung Cancer Spread
AI algorithms have been used to assess whether lung cancer will spread, and they outperformed clinicians.Original story from California Institute of Technology Lung Cancer Metastasis. Credit: Scott Wilkinson, Adam Marcus/ National Cancer InstituteFor decades, scientists and pathologists have tried, without much success, to come up with a way to determine which individual lung cancer patients...